May 25, 2017 9:58 PM ET

Biotechnology

Company Overview of Spectrum Pharmaceuticals, Inc.

Executive Profile

Bimal R. Shah

Vice President of Corporate and Business Development, Spectrum Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

----

Background

Mr. Bimal R. Shah serves as Vice President of Corporate and Business Development at Spectrum Pharmaceuticals, Inc., and served as its Vice President of Finance - Business Development. Mr. Shah serves as the Chief Financial Officer and Treasurer at Allos Therapeutics, Inc. Mr. Shah was an Associate at Warburg Pincus LLC. He worked at New York office and was a Member of Healthcare and Biotechnology Group. Prior to joining Warburg Pincus in 2005, Mr. Shah was employed in ...

Corporate Headquarters

11500 South Eastern Avenue
Henderson, Nevada 89052

United States

Phone: 702-835-6300
Fax: 702-260-7405

Board Members Memberships

There is no Board Members Memberships data available.

Education

MA
Stanford University
BA
Stanford University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Amit D. Munshi Chief Executive Officer, President and Director
Arena Pharmaceuticals, Inc.
$397.8K
Friedhelm Blobel Ph.D.Chief Executive Officer, President and Executive Director
SciClone Pharmaceuticals, Inc.
$650.0K
Mark R. Baker J.D.Chief Executive Officer and Director
Progenics Pharmaceuticals, Inc.
$646.8K
Richard Peters M.D., Ph.D.Chief Executive Officer, President and Director
Merrimack Pharmaceuticals, Inc.
--
Charles J. Link Jr., M.D.Co-Founder, Chairman, Chief Executive Officer and Chief Scientific Officer
NewLink Genetics Corporation
$714.9K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Spectrum Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.